SMS Pharmaceuticals Ltd
Company Profile
Business description
SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company specialising in Active Pharmaceutical Ingredients (API) and complex intermediates for customers globally. Its product portfolio comprises several APIs across different therapeutic segments, with a substantial presence in key categories including anti-diabetic, antiretroviral (ARV), anti-inflammatory, anti-migraine, and anti-ulcer. The operations of the company are limited to one segment, viz. Pharmaceutical products, including ingredients and intermediaries. Geographically, the company derives maximum revenue through export of its products to its customers in North America, Europe, and other regions, and the rest from its business in India.
Contact
Trendset Jayabheri Connect
8th Floor, Kondapur
Ranga Reddy District
Serilingampally
HyderabadTG500084
INDT: +91 4069859999
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2027
Employees
1,470
Stocks News & Analysis
stocks
ASX biotech expands diagnostics portfolio after FDA approval
stocks
Is it time to bail on Australian stocks?
stocks
ASX share undervalued despite margin woes
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,874.50 | 25.20 | 0.28% |
| CAC 40 | 8,140.06 | 49.78 | 0.62% |
| DAX 40 | 25,497.85 | 95.57 | 0.38% |
| Dow JONES (US) | 52,093.11 | 328.09 | -0.63% |
| FTSE 100 | 10,727.08 | 68.95 | 0.65% |
| HKSE | 24,713.78 | 46.54 | 0.19% |
| NASDAQ | 25,981.57 | 204.84 | -0.78% |
| Nikkei 225 | 63,923.00 | 438.90 | 0.69% |
| NZX 50 Index | 13,622.72 | 138.50 | 1.03% |
| S&P 500 | 7,585.73 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,696.50 | 24.00 | 0.28% |
| SSE Composite Index | 3,891.60 | 27.32 | 0.71% |